Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT for High Frequency Episodic Migraine Without Aura
NCT03461874Completed
- Sponsor
- Carlo Besta Neurological Institute
- Start
- Mar 2018
- Primary completion
- Jul 2020
- Countries
- 1
01
Overview
Randomised, open-label trial in migraine without aura (2 arms), sponsored by Carlo Besta Neurological Institute. Primary endpoint: Reduction of headaches frequency at 12 months. Started Mar 2018; status: completed.
02
Conditions
migraine without aura
Beyond the preview
Go deeper on NCT03461874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03461874.